LMO2 and acute lymphoblastic leukemia: Five different molecular pathways have been previously identified, leading to T-ALL, involving activation of different T-ALL oncogenes; HOX11, HOX11L2, TAL1, LMO1/2, LYL1, LMO2, and MLL-ENL.